Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$PMCB Pharmacyte Biotech Inc (OTCMKTS:PMCB) Is Targeting The Deadliest Cancer In The US PMCB
Pharmacyte Biotech Inc (OTCMKTS:PMCB) is a company that we keep coming back to and it’s been a real winner over the last few months. Back at the end of November, the company traded for less than $0.05 a share. At the end of last year, Pharmacyte stock traded up to $0.15 a share, and has since corrected to current levels somewhere in the region of $0.11. Even with the recent correction taken into consideration, that’s still a 120% increase during the period in question.
Last week, the company announced its intentions to initiate a clinical trial in pancreatic cancer, and we believe this trial could be a real value driver going forward. As yet, markets have not responded to the news, presenting an opportunity to pick up a discounted exposure in anticipation of said response.
We have covered this one on a number of occasions in the past, so we won’t go into too much detail on operations here. By way of a brief introduction, however, the company has developed a technology that allows for a targeted and potent delivery of a chemotherapy agent (variable, depending upon the type of cancer being treated). The technology, called Cell in a Box, removes the necessity for liver pass activation of the chemo agent, and this – in turn – allows for efficacy at a much lower dose. To put this another way, traditional chemotherapy requires the active agents to pass through the liver in order to become active (there are certain enzymes in the liver that activate the key compound). With this system, however, the active compound is injected (encased within the technology) directly at the tumor site, and then activated post delivery. Targeted treatment translates to lower dose necessity, which in turn translates to lower toxicity. Reduced toxicity removes the side effects commonly associated with cancer treatment.
Anyway, the latest announcement relates to an application of this technology targeted at the above-mentioned pancreatic cancer. For the last 10 years, the gold standard in pancreatic cancer treatment has been a drug called gemcitabine, which was developed, and is now marketed by, Eli Lilly and Co (NYSE:LLY). It is the gold standard, but it’s not that great. Pancreatic cancer remains the deadliest cancer in the US (in terms of one and five year survival rates) and – despite this – most new treatments focus on acting as an adjuvant to Eli’s gemcitabine, as opposed to an improvement/replacement.
Pharmacyte is trying to change this with its therapy.
The drug will go head-to-head with gemcitabine, with one arm of the trial treated using Pharmacyte’s therapy, and the other treated with gemcitabine (double blinded). We see this study as providing numerous near-term catalysts for the company going forward, with the first being the announcement of the phase 1 getting underway. The company has completed a pre-IND meeting with the FDA, and the assumption is that it has a trial protocol in hand with which it can its assets carry forward into clinical development. According to recent communication, management expects to hold a conference call on or around February 8, at which point we expect some further insight into exactly how the trial is structured, and when we can expect data to hit press.
As ever, at this end of the biotechnology market, cash on hand is a bit of concern. The company reported $1.55 million cash and cash equivalents at last count (October 31, 2016) and as such, will likely have to raise equity before mid to late 2017. This raise will probably be dilutive, and while it doesn’t negate the upside potential of the trial’s initiation, it should be taken into consideration ahead of an exposure.
We’re watching closely for any suggestion as to when this trial will get underway, and we’ll sit in on the February conference call to solidify our expectations and support our bias.
$BMSPF $88 Million in Bond Financing approved by Governor of Louisiana for Biomass Secure Power. (Biomass Power Louisiana)
http://gov.louisiana.gov/assets/ExecutiveOrders/JBE17-03.pdf
Do your DD on this NO BRAINER on it's way to the AMEX in 2017!
$40 million annual contract in hand for 20 years.
$400 million MOU for up to 2 million tonnes of Bio-Coal annually.
$ASTI Loading Zone. #Solar
$ICNB - closed up 1900% last week, making it the 5th largest WINNER ever on this board...
SPQS could be next one
It's bullshit. One company got suspended cause they were late filing reports. The other link doesn't work. I find ZERO evidence using Bing that Erwin Vahlsing is involved in any fraud/scam whatsoever.........z
$PMCB PharmaCyte Biotech’s Cannabinoid Therapy May Offer Potential for Childhood Brain Cancers PMCB
https://globenewswire.com/news-release/2016/12/27/901802/0/en/PharmaCyte-Biotech-s-Cannabinoid-Therapy-May-Offer-Potential-for-Childhood-Brain-Cancers.html
Go $PMCB
$FDBL "Friendable" App Featured in Fifth Harmony Featuring Fetty Wap Music Video -- "Flex" 146+ Million Views
$VPOR Total Vapor, Shifts Focus to Cannabis-Related Products "We have started two new projects involving the development of exciting new products specific to the increasing use of cannabis in the several states in which it is now legal. Going forward these products will represent a baseline of growth for Total Vapor as it increases its focus on the MJ Market." He continued, "The plan is for Total Vapor to spin-off from NewGen Concepts, Inc. in the near future, wherein Total Vapor will then become an independent publicly traded company with products totally immersed in the MJ Market. In the coming weeks, we expect to announce our first such proprietary Cannabis-related products that will significantly drive Total Vapor's revenues and earnings in the future." https://finance.yahoo.com/news/newgen-concepts-inc-formerly-vapor-130000330.html
$FDBL Momentum building
Watch $FDBL for .003's today
$SIPC OTC Stock Pattern to Watch: Is Buying SIPP INDUSTRIES NEW (SIPC) Here Winning Strategy? SIPC
Upon recent trading, SIPP INDUSTRIES NEW (OTCMKTS:SIPC) shares caught focus of OTC traders as the price moved $-0.0001, touching the $0.0051 price point.
https://goo.gl/AO07US
Board marked ;)
$ICNB, $OWCP, $CYDY$
GLTA
War
I only started following stock pick boards in the last year. Great way to find what's hot, and what's moving!
It looks to still be pretty active.
Thanks... No time to actively work the picks these days... back in the day, it was one of I-hubs top boards...
Just checked out your board when I saw you mention it on the ICNB board!
Nice!
On my Favorites now!
$GLUU Glu Mobile Inc. develops, publishes, and markets a portfolio of games for the smartphones and tablet devices users. The company offers free-to-play action, celebrity, sports, and simulation genre mobile games. It creates games based on its own brands, including Contract Killer, Cooking Dash, Deer Hunter, Diner Dash, Eternity Warriors, Frontline Commando, Gun Bros, Heroes of Destiny, Racing Rivals, Tap Sports Baseball, and Tap Sports Football. The company also creates games based on third-party licensed brands, such as Kim Kardashian: Hollywood, Kendall and Kylie, Katy Perry Pop, James Bond: World of Espionage, Mission Impossible: Rogue Nation, and Sniper X With Jason Statham. Glu Mobile Inc. markets, sells, and distributes its games primarily through direct-to-consumer digital storefronts worldwide. The company was formerly known as Sorrent, Inc. and changed its name to Glu Mobile Inc. in May 2005. Glu Mobile Inc. was incorporated in 2001 and is headquartered in San Francisco, California.
$ISBG Cavôda Vodka is an ultra premium vodka with a modern twist; it combines the smooth taste of 5x distilled, whole wheat grain French vodka with a unique LED light feature that will illuminate any room. With the flip of an easy-to-use switch located at the base of the bottle, the glow from the blue or pink bottle will catch anyone’s eye.
For the consumer with discerning taste who’s looking to stand out in a crowd, Cavôda Vodka is the perfect marriage of superior quality and innovative design.
www.cavodavodka.com
$PMCB Pharmacyte Biotech Inc (OTCMKTS:PMCB) Targeting To Produce 6-Month Revolutionary Data PMCB
http://www.mmjobserver.com/pharmacyte-biotech-inc-otcmktspmcb-targeting-to-produce-6-month-revolutionary-data/8961/
Go $PMCB
$PMCB Pharmacyte Biotech Inc (OTCMKTS:PMCB) Progress With Patients Enrollment In Pancreatic Cancer Clinical Study PMCB
https://www.journaltranscript.com/2016/12/pharmacyte-biotech-inc-otcmktspmcb-progress-with-patients-enrollment-in-pancreatic-cancer-clinical-study/
Congrats to you as well and I am super super happy with PMCB
Congrats... I'm doing well on $INCB... as well! Should hit pennyland or multi-pennies...
$PMCB thanks Buddy....banking big on this one and grab a tons of shares when it hit $.04 and now it is awesome
I'm calling $ICNB .0016 as a NOBRAINER...$ICNB.0016 Soared up 78% today, You-won't-believe-this....
You gotta see what's in the I-box on the $ICNB I-hub board...
http://investorshub.advfn.com/Iconic-Brands-Inc-ICNB-15837/
This is why $ICNB is starting to run!
Nice NOBRAINER on $PMCB Pete!
Nice - new POT STOCK - $CSOC in-the-BUZZ-CLOUD-now...
http://investorshub.advfn.com/boards/tcloud2.aspx?i=1
This one is getting a lot of attention after last couple of weeks updates and SEC 8K filings..
Only 109 million share float - NO DILUTION - NO CONVERTIBLES - NO CURRENT DEBTS - Confirmed..
Big BREAKOUT last week...
$PMCB GENE THERAPY FOR TYPE 1 DIABETES
Ann M. Simpson
Centre for Health Technologies
http://www.uts.edu.au/sites/default/files/sci-infectious-diseases-presentation-ann-simpson.pdf
http://pharmacyte.com/diabetes/
Go $PMCB
$PMCB FDA and EMA ODD Granted
FDA Grants Orphan Drug Designation to Pharmacyte Biotech for Pancreatic Cancer Treatment
http://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=457014
PharmaCyte Biotech Obtains Orphan Drug Designation in Europe for Its Pancreatic Cancer Treatment
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/orphans/2009/11/human_orphan_000395.jsp&mid=WC0b01ac058001d12b
$CHRO: Top 5 Smart Devices for your Home Automation
$CHRO: 5 Smart Home devices you will buy
$SDVI, $SWHI, $SURE, $SFOR: $.0001-.0010 lottos
$CHRO: Smart Home Highlights at CES 2016
$GNPT: has a big chance of moving back to $.00x range
***** $SURE: The next 10-50x bagga; thin, thin float, small O/S *****
Ubiquitech Software Corp. Announces Revenue From Its HempLife Today Division Increased 36% From the Prior Quarter
Source: InvestorsHub NewsWire
Ubiquitech Software Corp.
Ubiquitech Software Corp. Announces Revenue From Its HempLife Today Division Increased 36% From the Prior Quarter and 25% Year Over Year to $906,352
DENVER, CO--(NewMediaWire - Oct 6, 2016) - Ubiquitech Software Corp. (OTC PINK: UBQU), with pending symbol and name change to HempLife Today™ is pleased to report that revenues from its Popular line of hemp derived CannazALL™ CBD products exceeded $906,000 for the current quarter, and earnings rose to $81,324 from a loss of $(24,884) in the year ago period.
The company achieved and exceeded its goals of 3rd quarter growth through its proprietary and strategic marketing campaigns and valuable robust word-of-mouth viral advertising. In addition to its new CannazALL™ products, that continue to bring in new customers, the company has also continued to lower its customer acquisition costs from a high of $200 per customer at this time last year, to under $25 per customer in 3rd quarter 2016.
CEO of HempLife Today™ James Ballas said, "We have a solid plan for growth and profits for the company and this is what allows us to grow at an ever increasing rate. Everything we have done up to now, our first three years in this business, was to get us into this position and ready to become the major player in the industry. We are pleased, but not surprised, at what we have already accomplished."
The company currently has plans (previously released), to more than triple the number of customers for its CannazALL™ CBD products in 2017. This is being done through an increase in Internet awareness of the company and its products, increased Referrals, increased social media, direct mail campaigns, and the incredible viral "word of mouth" advertising the company experiences.
"I keep saying it because we mean it," adds James Ballas. "If people think this year has been good just wait and see what we have planned for 4th quarter 2016 and throughout 2017, because we are set up for nothing but growth."
The company also has a new name (HempLife Today™) and symbol change pending and will release this information as soon as possible.
About Ubiquitech (HempLife Today™)
Ubiquitech Software Corp, through its subsidiaries is a dynamic multi-media, multi-faceted corporation utilizing state-of-the-art global internet marketing, Direct Response (DRTV) Television, Radio, and traditional marketing, to drive traffic to the new and emerging multi-billion dollar industries like its subsidiary HempLifeToday.com™
HempLifeToday™ focuses on the exciting and dynamic new thinking in the world today that recognizes the important health and life enriching enhancement that CBD Oil from the Hemp plant can bring. Through its network of quality USA growers HempLifeToday.com™ has developed multiple and proprietary CannazALL™ CBD oil products that include; It's popular CBD Tinctures, Oils, GelCaps, CBD Powder, Skin Salve, Wax Crumble, and e-liquid, all offered @ www.HempLifeToday.com
This press release contains forward-looking statements. Words such as "expects", "intends'', "believes'', and similar expressions reflecting something other than historical fact are intended to identify forward-looking statements, but are not the exclusive means of identifying such statements. These forward-looking statements involve a number of risks and uncertainties, including the timely development and market acceptance of products and technologies, the ability to secure additional sources of finance, the ability to reduce operating expenses, and other factors described in the Company's filings with the OTC Markets Group. The actual results that the Company achieves may differ materially from any forward-looking statement due to such risks and uncertainties. The Company undertakes no obligation to revise or update any forward- looking statements in order to reflect events or circumstances that may arise after the date of this release.
CONTACT INFORMATION
Contact:
Investor Relations
E-mail: Investors@UbiquitechSoftware.com
***** $CHRO: could run like TT** (II), MG* (T), CG**(RW), etc. from $.00x or for low $.0x to $1.00s+ *****
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=122551963
$SURE, $COBI, $LUSI, $GNPT, $VGID: Super thin...take little to get to mid $.00x range
$COBI: could be a 10-50x bagga in the long-run
Followers
|
409
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
10176
|
Created
|
12/31/06
|
Type
|
Free
|
Moderator Drugdoctor | |||
Assistants kermit42 MaxPowerLove$Ihub |
WELCOME to the NOBRAINERS BOARD
NO BRAINER HALL OF FAME!!!
ICNB.0305 Iconic Brands up 1900% picked by Drugdoctor on 12/21/16 at .0016 SMKY-Smokey Market Foods, Inc up 3650%..............Picked by DOLLARLAND on 3/9/11 at .012 GOIG-GOIP Global Inc - up 2150% ……………………………Picked by TurtleBK on 2/5/10 | ||||||||
ISML- ISM International - up 633%...................Picked by DOLLARLAND on 9/15/11 at .03 | ||||||||
FRHV- Fresh Harvest Products - up 502%...................Picked by Bliz82 on 3/13/10 | ||||||||
WDRP-Wanderport Corp - up 1054% …………………………..Picked by Burntwood on 2/1/10 | ||||||||
CCTC-Clean Coal technologies - up 733%....................Picked by Daytrader2008 on 2/15/10 | ||||||||
DLCR-David Loren Corp - up 500% ………………………………..Picked by creppie on 1/1/10 | ||||||||
AAGH - Asia Global Holdings, peaked up 608.16% ......................Picked by Charlatan on 2/13/07 | ||||||||
AMPE/HVAE - High Velocity Alternative Energy, peaked up 519%....................Picked by Obi_Penny_Kanobi on 08/09/07 | ||||||||
ATLJ - Asia Telecom, Ltd peaked at 804.76%........................Picked by pop-a-top on 01/19/07 | ||||||||
COPI - Compliance Systems up 2310% .........................Picked by kermit42 on 08/27/07 at .0039 | ||||||||
DPDW -- Deep Down Inc. peaked at 980%..................Picked by brikk on 1/1/07 | ||||||||
EESO --Enzyme Environmental Soln. up 3900% - picked by burp on 03/26/08 at .0007 | ||||||||
HMGP - Hemi Energy Group Inc. peaked at 505% ...................Picked by lowman on 01/01/07 | ||||||||
PDGT - Paradigm Tactical Products, Inc. up 500%........................picked by kraigger23 on 5/6/07 | ||||||||
SRSR - Sarissa Resources - up 12,352% picked by AngieM on 11/12/07 | ||||||||
```````````NO BRAINERS`````````````
The buzzwords of the 1990's - Rocket Ride - Train Leaving the Station - BACK UP THE TRUCK, LOAD THE BOAT, TO da MOON! Well, the 2010's are finally here, and THE NO BRAINERS are back!
All NASDAQ, OTCBB, and PINKIES are welcome, but please keep the price below $5 because we are looking for at least 50% gains on any pick posted! Also, the gain must occur within 6 months of the date posted! Let's not pick any stocks below .0005 because just the spread is 50% in a lot of cases. Also, if your pick retraces 25% after posting, it becomes a LAME BRAINER, and your pick is off the board.
So please - Post your NO BRAINER - but post your reason also. Please post the closing price. If you post a NOBRAINER while the market is open, come back and post the closing price please! Also, post a chart, and any other supporting links will be nice.
HOW TO POST A CHART IN A MESSAGE!
If you want to know how to show a chart in a post, here are the instructions, but PLEASE use the test board before posting here!
http://www.investorshub.com/boards/read_msg.asp?message_id=16557615
Use this link for a nice quick 3 month chart...
http://stockcharts.com/h-sc/ui?s=wegi&p=D&yr=0&mn=3&dy=0&id=p89527042396
If you think SIRI is finally going to post profits and the price will explode up over 50% from where it is now, then put it on the board. What we will try to do, is evaluate the suggestions and put the picks, the date, the price, and the poster name in the I-box.
So pick away, but remember, your picks will be here for all to see!!!
http://investorshub.advfn.com/boards/board.aspx?board_id=18435
"A Dawgg"
http://investorshub.advfn.com/boards/board.aspx?board_id=21519&NextStart=20
Watchlist
LAMEBRAINERS - in timeout - you can't pick these for awhile - they have failed the NOBRAINER test----
INIA
Please give feedback.
NOBRAINER INFO SECTION
NOBRAINERS Charts!
PRAXSYN Pharma
ELTP -ELITE Pharmaceutical
Disclaimer: These are penny stocks, very risky, and you may lose all your money if you invest in any NOBRAINER mentioned above. Also, we may trade in and out of any of the above securities at any time and without notice.
Posts Today
|
0
|
Posts (Total)
|
10176
|
Posters
|
|
Moderator
|
|
Assistants
|
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |